Cell4D Ltd.

The project contains significant red flags that necessitate a negative final score. While the core concept of nanofabricated biosensors paired with AI holds theoretical utility, the submission is severely compromised by false and contradictory claims. Assertions such as 'most people have used my product' and 'everyone' as the audience are blatantly inaccurate for a specialized biotechnology tool, especially when contrasted with an 'all-time marketcap' of 50000. These verifiable exaggerations result in heavy penalties across traction, reach, and response quality metrics.